Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal
NCT ID: NCT05169619
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
842 participants
OBSERVATIONAL
2021-04-30
2024-03-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
NCT04714567
Control and Burden of Asthma and Rhinitis
NCT01771120
A Study to Determine the Clinical Characteristics, Comorbidities, Treatment Status and Exacerbations of Asthma Patients
NCT03239431
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782
Identification of Asthma Phenotypes in Severe Asthmatics
NCT01623089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will conduct a population-based nationwide study with a multicentre stepwise approach, enrolling 7500 adult subjects, randomly selected, from the Portuguese National Health Service patients' database of 38 primary care centres:
STAGE 0 - Phone call invitation and enrolment of participants STAGE 1 - Telephone interview survey to assess respiratory symptoms. STAGE 2 - Clinical assessment, diagnostic confirmation, and patient characterization STAGE 3 - Characterization of asthma patients (sub-group) and characterization of difficult- to-treat asthma \& severe asthma patients after 3 months follow up period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Give voluntary signed informed consent,
* Ability to understand ans answer questionnaires.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculdade de Medicina da Universidade do Porto - CINTESIS
UNKNOWN
Universidade do Minho - ICVS
UNKNOWN
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
João Fonseca, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
cintesis
Jaime Correia de Sousa, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
ICVS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Alpendorada, Portugal, Portugal
Research Site
Vila Cova Da Lixa, Portugal, Portugal
Research Site
Aradas, , Portugal
Research Site
Arazede, , Portugal
Research Site
Braga, , Portugal
Research Site
Cascais, , Portugal
Research Site
Coimbra, , Portugal
Research Site
Evora, , Portugal
Research Site
Evora, , Portugal
Research Site
Fafe, , Portugal
Research Site
Leiria, , Portugal
Research Site
Lisbon, , Portugal
Research Site
Lisbon, , Portugal
Research Site
Lisbon, , Portugal
Research Site
Mafra, , Portugal
Research Site
Montenegro, , Portugal
Research Site
Oeiras, , Portugal
Research Site
Ovar, , Portugal
Research Site
Pinhal Novo, , Portugal
Research Site
Ponte, , Portugal
Research Site
Porto, , Portugal
Research Site
Porto, , Portugal
Research Site
Porto, , Portugal
Research Site
Porto, , Portugal
Research Site
Queluz, , Portugal
Research Site
Quinta Do Conde, , Portugal
Research Site
Ribeira de Pena, , Portugal
Research Site
Rio de Mouro, , Portugal
Research Site
Tavira, , Portugal
Research Site
Tomar, , Portugal
Research Site
Tondela, , Portugal
Research Site
Viana do Castelo, , Portugal
Research Site
Vila do Conde, , Portugal
Research Site
Vila Nova da Barquinha, , Portugal
Research Site
Vila Nova de Gaia, , Portugal
Research Site
Vila Real, , Portugal
Research Site
Vouzela, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jacome C, Brito D, Joao C, Lopes F, Santos J, Amorim L, Barbosa MJ, Pardal M, Teixeira P, Bernardo F, Fonseca JA, Correia-de-Sousa J. EPI-ASTHMA study protocol: a population-based multicentre stepwise study on the prevalence and characterisation of patients with asthma according to disease severity in Portugal. BMJ Open. 2022 Sep 19;12(9):e064538. doi: 10.1136/bmjopen-2022-064538.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D2287R00155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.